Inventiva S.A. (IVA)
$2.87-8.01%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $149M
- Beta
- 0.91
- P/E (TTM)
- -4.99
- Short % float
- 18.98%
- Days to cover
- 3.3
- SI change
- +72.0%
- 1W
- -17.05%
- 1M
- -26.03%
- vs SPY 1W
- -16.91%
- vs SPY 1M
- -28.54%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IVA?
- LOPJLB’s latest quantitative signal on Inventiva S.A. (IVA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IVA in?
- Inventiva S.A. (IVA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Inventiva S.A. (IVA) do?
- Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets serious conditions such as non-alcoholic steatohepatitis (NASH), various forms of mucopolysaccharidoses (MPS), and other significant diseases. The company's most advanced experimental drug is Lanifi…